# BARX2

## Overview
The BARX2 gene encodes the BARX homeobox 2 protein, a transcription factor characterized by its homeodomain, which is integral to its role in DNA binding and gene regulation. This protein is involved in various developmental processes, particularly in muscle differentiation and tissue morphogenesis, by regulating the expression of genes associated with cell adhesion and muscle-specific functions (Edelman2000The; Meech2003The). As a homeodomain protein, BARX2 interacts with other transcription factors and signaling pathways, such as the Wnt/β-catenin pathway, to modulate cellular differentiation and growth (Zhuang2014Barx2). Clinically, BARX2 has been implicated in cancer biology, where its expression levels can influence tumor progression and patient prognosis, acting as a potential biomarker in various cancers (Yu2023Pancancer; Mi2016Downregulation).

## Structure
The BARX2 protein is a homeodomain-containing transcription factor composed of 254 amino acids (Krasner2000Cloning). It features a homeodomain, a 61-amino acid DNA-binding structure, which is a hallmark of homeobox genes and forms a helix-turn-helix motif (Edelman2000The). This domain is crucial for binding to homeodomain binding sites (HBS) on genes encoding cell adhesion molecules (CAMs) such as L1, Ng-CAM, and N-CAM (Edelman2000The). The BARX2 protein also contains a 17-amino acid basic region known as the Barx basic region (BBR), which modulates DNA binding strength and specificity (Edelman2000The). 

The protein includes a putative leucine zipper and a polyalanine tract within its amino-terminal region, and an acidic domain within its carboxyl-terminal region (Edelman2000The). The leucine zipper motif is known for mediating protein-protein interactions, which may contribute to its regulatory functions (Edelman2000The). BARX2 interacts with members of the CREB family, specifically CREB1 and ATF2, which are leucine zipper-containing proteins (Edelman2000The). Phosphorylation of serine residues within the BBR reduces the DNA binding ability of BARX2, indicating a role for post-translational modifications in its function (Edelman2000The). The protein's structure and interactions suggest its involvement in transcriptional regulation during development.

## Function
The BARX2 gene encodes a homeodomain protein that plays a significant role in myogenic differentiation and muscle development. It is involved in the differentiation of skeletal and smooth muscle by promoting myotube formation and influencing the expression of genes necessary for myoblast differentiation, such as SM-α-actin (Meech2003The). BARX2 acts downstream of MyoD in the differentiation pathway, suggesting it does not activate MyoD but rather works in conjunction with it to regulate muscle-specific gene expression (Meech2003The).

BARX2 is also crucial for muscle growth and regeneration, as it is expressed in muscle progenitor cells, including satellite cells, and is required for normal muscle repair processes. In Barx2 null mice, impaired muscle growth and regeneration have been observed, highlighting its importance in these processes (Meech2012Barx2). The protein interacts with β-catenin, a key component of the Wnt signaling pathway, and is involved in regulating genes critical for muscle growth and repair, such as Dlk1 and Fst (Zhuang2014Barx2).

In addition to its role in muscle differentiation, BARX2 regulates cell adhesion molecules, which are crucial for cell interactions and the formation of cell collectives, indicating its broader role in tissue morphogenesis (Edelman2000The).

## Clinical Significance
The BARX2 gene plays a significant role in various cancers, with its expression levels and interactions influencing disease progression and patient outcomes. In gastric cancer, BARX2 is downregulated, which is associated with increased cell proliferation and metastasis, leading to poorer patient survival. This downregulation is linked to the inhibition of the Wnt/β-catenin signaling pathway, a critical pathway in tumorigenesis (Mi2016Downregulation). In colorectal cancer, lower BARX2 expression correlates with advanced disease stages and poor differentiation, serving as an independent prognostic biomarker for reduced disease-free and overall survival (Mi2016Downregulationa).

In liver hepatocellular carcinoma, BARX2 expression is lower in cancerous tissues, particularly in advanced stages, and is associated with poor prognosis. However, overexpression of BARX2 in this context is linked to better overall survival, suggesting its potential as a prognostic biomarker (Yu2023Pancancer). In bladder cancer, BARX2 acts as a tumor suppressor, with its overexpression reducing cell proliferation and invasion, highlighting its role in the circSHPRH/miR-942/BARX2/Wnt/β-catenin axis (Zuo2022Circular). These findings underscore the complex role of BARX2 in cancer, where its expression and interactions can either suppress or promote tumor progression depending on the cancer type.

## Interactions
BARX2 is a transcription factor that engages in various interactions with proteins and nucleic acids, influencing gene expression and cellular processes. It interacts with β-catenin to enhance histone acetylation at the Axin2 intronic enhancer, promoting active transcription in myoblasts. This interaction is facilitated by the histone acetyltransferase co-activator GRIP-1, which synergizes with BARX2 to boost Axin2 promoter activity (Hulin2016Barx2). BARX2 also forms complexes with members of the CREB family, specifically CREB1 and ATF2, through leucine zipper motifs, indicating a role in transcriptional regulation (Edelman2000The).

In muscle gene regulation, BARX2 binds to the homeodomain binding site (HBS) on the smooth muscle α-actin (SMA) promoter, working with MyoD and serum response factor (SRF) to enhance promoter activity. It physically interacts with MyoD and SRF, forming a complex crucial for full activation of the SMA gene (Makarenkova2009Barx2). BARX2 also interacts with TLE and N-CoR corepressor complexes, involving distinct regions of its N terminus, to regulate its own promoter activity in skin (Olson2005Barx2). These interactions highlight BARX2's multifaceted role in transcriptional regulation and cellular differentiation.


## References


[1. (Zhuang2014Barx2) Lizhe Zhuang, Julie-Ann Hulin, Anastasia Gromova, Thi Diem Tran Nguyen, Ruth T. Yu, Christopher Liddle, Michael Downes, Ronald M. Evans, Helen P. Makarenkova, and Robyn Meech. Barx2 and pax7 have antagonistic functions in regulation of wnt signaling and satellite cell differentiation. Stem Cells, 32(6):1661–1673, May 2014. URL: http://dx.doi.org/10.1002/stem.1674, doi:10.1002/stem.1674. This article has 25 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/stem.1674)

[2. (Hulin2016Barx2) Julie-Ann Hulin, Thi Diem Tran Nguyen, Shuang Cui, Shashikanth Marri, Ruth T. Yu, Michael Downes, Ronald M. Evans, Helen Makarenkova, and Robyn Meech. Barx2 and pax7 regulate axin2 expression in myoblasts by interaction with β-catenin and chromatin remodelling. Stem Cells, 34(8):2169–2182, June 2016. URL: http://dx.doi.org/10.1002/stem.2396, doi:10.1002/stem.2396. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/stem.2396)

[3. (Yu2023Pancancer) Shian Yu, Yu Yang, Hanqing Yang, Long Peng, Zhipeng Wu, Liang Sun, Zhengyi Wu, Xuzhe Yu, and Xiangbao Yin. Pancancer analysis of oncogenic barx2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma. Scientific Reports, May 2023. URL: http://dx.doi.org/10.1038/s41598-023-34519-8, doi:10.1038/s41598-023-34519-8. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-34519-8)

[4. (Edelman2000The) David B. Edelman, Robyn Meech, and Frederick S. Jones. The homeodomain protein barx2 contains activator and repressor domains and interacts with members of the creb family. Journal of Biological Chemistry, 275(28):21737–21745, July 2000. URL: http://dx.doi.org/10.1074/JBC.M909998199, doi:10.1074/jbc.m909998199. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M909998199)

[5. (Mi2016Downregulation) Yushuai Mi, Senlin Zhao, Chongzhi Zhou, Junyong Weng, Jikun Li, Zhanshan Wang, Huimin Sun, Huamei Tang, Xin Zhang, Xiaofeng Sun, Zhihai Peng, and Yugang Wen. Downregulation of homeobox gene barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes. Oncotarget, 7(37):60593–60608, August 2016. URL: http://dx.doi.org/10.18632/oncotarget.11260, doi:10.18632/oncotarget.11260. This article has 13 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.11260)

[6. (Krasner2000Cloning) Alan Krasner, Lalena Wallace, Arunthathi Thiagalingam, Christopher Jones, Christoph Lengauer, Lara Minahan, Yongkang Ma, Linda Kalikin, Andrew P. Feinberg, Ethylin Wang Jabs, Alan Tunnacliffe, Stephen B. Baylin, Douglas W. Ball, and Barry D. Nelkin. Cloning and chromosomal localization of the human barx2 homeobox protein gene. Gene, 250(1–2):171–180, May 2000. URL: http://dx.doi.org/10.1016/s0378-1119(00)00169-4, doi:10.1016/s0378-1119(00)00169-4. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(00)00169-4)

[7. (Meech2012Barx2) Robyn Meech, Katie N. Gonzalez, Marietta Barro, Anastasia Gromova, Lizhe Zhuang, Julie-Ann Hulin, and Helen P. Makarenkova. Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration. Stem Cells, 30(2):253–265, January 2012. URL: http://dx.doi.org/10.1002/stem.777, doi:10.1002/stem.777. This article has 37 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/stem.777)

[8. (Zuo2022Circular) Ling Zuo, Yi Zhu, Jinli Han, and Hongwei Liu. Circular rna circshprh inhibits the malignant behaviors of bladder cancer by regulating the mir-942/barx2 pathway. Aging, 14(4):1891–1909, February 2022. URL: http://dx.doi.org/10.18632/aging.203911, doi:10.18632/aging.203911. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.203911)

[9. (Olson2005Barx2) Lorin E. Olson, Jie Zhang, Havilah Taylor, David W. Rose, and Michael G. Rosenfeld. Barx2 functions through distinct corepressor classes to regulate hair follicle remodeling. Proceedings of the National Academy of Sciences, 102(10):3708–3713, February 2005. URL: http://dx.doi.org/10.1073/pnas.0500519102, doi:10.1073/pnas.0500519102. This article has 37 citations.](https://doi.org/10.1073/pnas.0500519102)

[10. (Meech2003The) Robyn Meech, Helen Makarenkova, David B. Edelman, and Frederick S. Jones. The homeodomain protein barx2 promotes myogenic differentiation and is regulated by myogenic regulatory factors. Journal of Biological Chemistry, 278(10):8269–8278, March 2003. URL: http://dx.doi.org/10.1074/JBC.M207617200, doi:10.1074/jbc.m207617200. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M207617200)

[11. (Makarenkova2009Barx2) Helen P. Makarenkova, Katie N. Gonzalez, William B. Kiosses, and Robyn Meech. Barx2 controls myoblast fusion and promotes myod-mediated activation of the smooth muscleα-actin gene. Journal of Biological Chemistry, 284(22):14866–14874, May 2009. URL: http://dx.doi.org/10.1074/jbc.M807208200, doi:10.1074/jbc.m807208200. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M807208200)

[12. (Mi2016Downregulationa) Yushuai Mi, Senlin Zhao, Weihao Zhang, Dongyuan Zhang, Junyong Weng, Kejian Huang, Huimin Sun, Huamei Tang, Xin Zhang, Xiaofeng Sun, Zhihai Peng, and Yugang Wen. Down-regulation of barx2 predicts poor survival in colorectal cancer. Biochemical and Biophysical Research Communications, 478(1):67–73, September 2016. URL: http://dx.doi.org/10.1016/j.bbrc.2016.07.091, doi:10.1016/j.bbrc.2016.07.091. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2016.07.091)